Cargando…
SARS–CoV–2 Spike Impairs DNA Damage Repair and Inhibits V(D)J Recombination In Vitro
Severe acute respiratory syndrome coronavirus 2 (SARS–CoV–2) has led to the coronavirus disease 2019 (COVID–19) pandemic, severely affecting public health and the global economy. Adaptive immunity plays a crucial role in fighting against SARS–CoV–2 infection and directly influences the clinical outc...
Autores principales: | Jiang, Hui, Mei, Ya-Fang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8538446/ https://www.ncbi.nlm.nih.gov/pubmed/34696485 http://dx.doi.org/10.3390/v13102056 |
Ejemplares similares
-
Retraction: Jiang, H.; Mei, Y.-F. SARS-CoV-2 Spike Impairs DNA Damage Repair and Inhibits V(D)J Recombination In Vitro. Viruses 2021, 13, 2056
por: Jiang, Hui, et al.
Publicado: (2022) -
Expression of Concern: Jiang, H.; Mei, Y.-F. SARS-CoV-2 Spike Impairs DNA Damage Repair and Inhibits V(D)J Recombination In Vitro. Viruses 2021, 13, 2056
por: Freed, Eric O., et al.
Publicado: (2021) -
Cell-Free Glycoengineering of the Recombinant SARS-CoV-2 Spike Glycoprotein
por: Ruhnau, Johannes, et al.
Publicado: (2021) -
Mediator of DNA Damage Checkpoint Protein 1 Facilitates V(D)J Recombination in Cells Lacking DNA Repair Factor XLF
por: Beck, Carole, et al.
Publicado: (2019) -
A urine-based ELISA with recombinant non-glycosylated SARS-CoV-2 spike protein for detecting anti-SARS-CoV-2 spike antibodies
por: Ramos, Fernanda F., et al.
Publicado: (2023)